Who is sponsoring NCT03889470?

NCT03889470 is sponsored by Hermina Heart Center Kemayoran.

What drugs are being tested in NCT03889470?

Interventions in NCT03889470: NTG 1 MG/ML Injectable Solution.

What condition does NCT03889470 study?

NCT03889470 studies Radial Artery Injury.

Is NCT03889470 still recruiting?

NCT03889470 is currently status unknown. Last updated 4 June 2019.

Last reviewed 2019-06-04 · How we verify

NCT03889470: NORAS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nitroglycerin as Spasmolytic Regimen for RAS Prevention in Radial Center

Status unknown Phase 4 Last updated 4 June 2019

What this trial tests

Phase 4 trial testing NTG 1 MG/ML Injectable Solution in Radial Artery Injury in 1,000 participants. Status unknown.

Timeline

31 March 2018

Primary endpoint
30 September 2019

1 October 2019

Quick facts

Lead sponsor	Hermina Heart Center Kemayoran
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	1,000
Start date	31 March 2018
Primary completion	30 September 2019
Estimated completion	1 October 2019
Sites	1 location across Indonesia

Drugs / interventions tested

NTG 1 MG/ML Injectable Solution — full drug profile →

Conditions studied

Radial Artery Injury — all drugs for Radial Artery Injury →

Sponsor

Hermina Heart Center Kemayoran — full company profile →

Who can join

Eligibility, any sex, with Radial Artery Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators will investigate whether administration of Nitroglycerin (NTG) as spasmolytic regimen reduces the incidence of moderate to severe radial artery spasm (RAS) in patients undergoing transradial catheterization in radial center.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Hermina Heart Center Kemayoran trials

Trials by the same sponsor.

NCT03622060 — Intraarterial Nitroglycerin Versus Nicardipine and Radial Artery Occlusion · Phase 3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03889470 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hermina Heart Center Kemayoran
Last refreshed: 4 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03889470.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing